APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Metabolism and Pharmacokinetics (DMPK) Service

Compare research editions
View pricing & licenses

Selected research

Industry Research

Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Research Report 2026

2 May 2026141 pages

Choose your research edition.

Industry ResearchDrug Metabolism and Pharmacokinetics (DMPK) Service Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Drug Metabolism and Pharmacokinetics (DMPK) Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Metabolism and Pharmacokinetics (DMPK) Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Metabolism and Pharmacokinetics (DMPK) Service Market Analysis and Forecast 2026-2032184 pages · $4,950 USD

Market perspective

The global Drug Metabolism and Pharmacokinetics (DMPK) Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Drug Metabolism and Pharmacokinetics (DMPK) Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Metabolism and Pharmacokinetics (DMPK) Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Metabolism and Pharmacokinetics (DMPK) Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Metabolism and Pharmacokinetics (DMPK) Service include NuChem Sciences Inc, Sygnature Discovery, Paraza Pharma, Inc, Dalriada, Inotiv, Eurofins Discovery, RTI International, Frontage Labs and Labcorp, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Drug Metabolism and Pharmacokinetics (DMPK) Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Metabolism and Pharmacokinetics (DMPK) Service.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Drug Metabolism and Pharmacokinetics (DMPK) Service Market by Company

NuChem Sciences Inc

Sygnature Discovery

Paraza Pharma, Inc

Dalriada

Inotiv

Eurofins Discovery

RTI International

Frontage Labs

Labcorp

Jubilant Biosys

Creative Biolabs

Evotec

Charles River

Anthem Bio Sciences

Molecular Diagnostic Services, Inc

Invitrocue

TCG Lifesciences Private Limited

Q 2 Solutions

WuXi AppTec

oncodesign service

Alliance Pharma, Inc

QPS Holdings

NUVISAN

Drug Metabolism and Pharmacokinetics (DMPK) Service Segment by Type

In Vivo Drug Metabolism and Pharmacokinetics Services

In Vitro Drug Metabolism and Pharmacokinetics Services

Drug Metabolism and Pharmacokinetics (DMPK) Service Segment by Application

Pharmaceutical Research and Development

Biotechnology

Efficacy Testing

Others

Drug Metabolism and Pharmacokinetics (DMPK) Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Metabolism and Pharmacokinetics (DMPK) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Metabolism and Pharmacokinetics (DMPK) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Metabolism and Pharmacokinetics (DMPK) Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Drug Metabolism and Pharmacokinetics (DMPK) Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Type (2021-2026) Table 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Type (2027-2032) Table 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Application (2021-2026) Table 11. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Application (2027-2032) Table 13. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2021-2026) Table 16. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2027-2032) Table 18. Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Trends Table 19. Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Drivers Table 20. Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Opportunities and Challenges Table 21. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Restraints Table 22. Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Players (2021-2026) Table 24. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Headquarters and Area Served Table 26. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Drug Metabolism and Pharmacokinetics (DMPK) Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027-2032) & (US$ Million) Table 45. NuChem Sciences Inc Company Information Table 46. NuChem Sciences Inc Business Overview Table 47. NuChem Sciences Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 48. NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 49. NuChem Sciences Inc Recent Developments Table 50. Sygnature Discovery Company Information Table 51. Sygnature Discovery Business Overview Table 52. Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 53. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 54. Sygnature Discovery Recent Developments Table 55. Paraza Pharma, Inc Company Information Table 56. Paraza Pharma, Inc Business Overview Table 57. Paraza Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 58. Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 59. Paraza Pharma, Inc Recent Developments Table 60. Dalriada Company Information Table 61. Dalriada Business Overview Table 62. Dalriada Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 63. Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 64. Dalriada Recent Developments Table 65. Inotiv Company Information Table 66. Inotiv Business Overview Table 67. Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 68. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 69. Inotiv Recent Developments Table 70. Eurofins Discovery Company Information Table 71. Eurofins Discovery Business Overview Table 72. Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 73. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 74. Eurofins Discovery Recent Developments Table 75. RTI International Company Information Table 76. RTI International Business Overview Table 77. RTI International Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 78. RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 79. RTI International Recent Developments Table 80. Frontage Labs Company Information Table 81. Frontage Labs Business Overview Table 82. Frontage Labs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 83. Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 84. Frontage Labs Recent Developments Table 85. Labcorp Company Information Table 86. Labcorp Business Overview Table 87. Labcorp Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 88. Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 89. Labcorp Recent Developments Table 90. Jubilant Biosys Company Information Table 91. Jubilant Biosys Business Overview Table 92. Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 93. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 94. Jubilant Biosys Recent Developments Table 95. Creative Biolabs Company Information Table 96. Creative Biolabs Business Overview Table 97. Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 98. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 99. Creative Biolabs Recent Developments Table 100. Evotec Company Information Table 101. Evotec Business Overview Table 102. Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 103. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 104. Evotec Recent Developments Table 105. Charles River Company Information Table 106. Charles River Business Overview Table 107. Charles River Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 108. Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 109. Charles River Recent Developments Table 110. Anthem Bio Sciences Company Information Table 111. Anthem Bio Sciences Business Overview Table 112. Anthem Bio Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 113. Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 114. Anthem Bio Sciences Recent Developments Table 115. Molecular Diagnostic Services, Inc Company Information Table 116. Molecular Diagnostic Services, Inc Business Overview Table 117. Molecular Diagnostic Services, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 118. Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 119. Molecular Diagnostic Services, Inc Recent Developments Table 120. Invitrocue Company Information Table 121. Invitrocue Business Overview Table 122. Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 123. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 124. Invitrocue Recent Developments Table 125. TCG Lifesciences Private Limited Company Information Table 126. TCG Lifesciences Private Limited Business Overview Table 127. TCG Lifesciences Private Limited Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 128. TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 129. TCG Lifesciences Private Limited Recent Developments Table 130. Q 2 Solutions Company Information Table 131. Q 2 Solutions Business Overview Table 132. Q 2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 133. Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 134. Q 2 Solutions Recent Developments Table 135. WuXi AppTec Company Information Table 136. WuXi AppTec Business Overview Table 137. WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 138. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 139. WuXi AppTec Recent Developments Table 140. oncodesign service Company Information Table 141. oncodesign service Business Overview Table 142. oncodesign service Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 143. oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 144. oncodesign service Recent Developments Table 145. Alliance Pharma, Inc Company Information Table 146. Alliance Pharma, Inc Business Overview Table 147. Alliance Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 148. Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 149. Alliance Pharma, Inc Recent Developments Table 150. QPS Holdings Company Information Table 151. QPS Holdings Business Overview Table 152. QPS Holdings Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 153. QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 154. QPS Holdings Recent Developments Table 155. NUVISAN Company Information Table 156. NUVISAN Business Overview Table 157. NUVISAN Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) & (US$ Million) Table 158. NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio Table 159. NUVISAN Recent Developments Table 160. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Drug Metabolism and Pharmacokinetics (DMPK) Service Product Image Figure 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Type: 2025 VS 2032 Figure 7. In Vivo Drug Metabolism and Pharmacokinetics Services Product Figure 8. In Vitro Drug Metabolism and Pharmacokinetics Services Product Figure 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Application: 2025 VS 2032 Figure 11. Pharmaceutical Research and Development Product Figure 12. Biotechnology Product Figure 13. Efficacy Testing Product Figure 14. Others Product Figure 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region: 2025 VS 2032 Figure 18. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Players in 2025 Figure 19. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Manufacturers Established Date Figure 20. Global Top 5 and 10 Drug Metabolism and Pharmacokinetics (DMPK) Service Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2032) Figure 24. United States Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2032) Figure 27. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2032) Figure 29. Germany Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2032) Figure 39. China Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2032) Figure 44. Australia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021-2032) Figure 49. Brazil Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. NuChem Sciences Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 55. Sygnature Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 56. Paraza Pharma, Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 57. Dalriada Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 58. Inotiv Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 59. Eurofins Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 60. RTI International Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 61. Frontage Labs Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 62. Labcorp Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 63. Jubilant Biosys Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 64. Creative Biolabs Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 65. Evotec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 66. Charles River Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 67. Anthem Bio Sciences Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 68. Molecular Diagnostic Services, Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 69. Invitrocue Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 70. TCG Lifesciences Private Limited Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 71. Q 2 Solutions Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 72. WuXi AppTec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 73. oncodesign service Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 74. Alliance Pharma, Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 75. QPS Holdings Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026) Figure 76. NUVISAN Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)

Scope & coverage.

Types
  • In Vivo Drug Metabolism and Pharmacokinetics Services
  • In Vitro Drug Metabolism and Pharmacokinetics Services
Applications
  • Pharmaceutical Research and Development
  • Biotechnology
  • Efficacy Testing
  • Others
Companies covered
  • NuChem Sciences Inc
  • Sygnature Discovery
  • Paraza Pharma, Inc
  • Dalriada
  • Inotiv
  • Eurofins Discovery
  • RTI International
  • Frontage Labs
  • Labcorp
  • Jubilant Biosys
  • Creative Biolabs
  • Evotec
  • Charles River
  • Anthem Bio Sciences
  • Molecular Diagnostic Services, Inc
  • Invitrocue
  • TCG Lifesciences Private Limited
  • Q 2 Solutions
  • WuXi AppTec
  • oncodesign service
  • Alliance Pharma, Inc
  • QPS Holdings
  • NUVISAN

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Drug Metabolism and Pharmacokinetics (DMPK) Service by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 In Vivo Drug Metabolism and Pharmacokinetics Services
  5. 2.2.3 In Vitro Drug Metabolism and Pharmacokinetics Services
  6. 2.3 Drug Metabolism and Pharmacokinetics (DMPK) Service by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Pharmaceutical Research and Development
  9. 2.3.3 Biotechnology
  10. 2.3.4 Efficacy Testing
  11. 2.3.5 Others
  12. 2.4 Assumptions and Limitations
3 Drug Metabolism and Pharmacokinetics (DMPK) Service Breakdown Data by Type
  1. 3.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size by Type (2021-2026)
  2. 3.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Type (2027-2032)
4 Drug Metabolism and Pharmacokinetics (DMPK) Service Breakdown Data by Application
  1. 4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size by Application (2021-2026)
  2. 4.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Perspective (2021-2032)
  2. 5.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Growth Trends by Region
  3. 5.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size by Region (2021-2026)
  5. 5.2.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Region (2027-2032)
  6. 5.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Dynamics
  7. 5.3.1 Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Trends
  8. 5.3.2 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Drivers
  9. 5.3.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Challenges
  10. 5.3.4 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Revenue
  2. 6.1.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Revenue (2021-2026)
  3. 6.1.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service Head Office and Area Served
  6. 6.4 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Players, Product Type & Application
  7. 6.5 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Manufacturers Established Date
  8. 6.6 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021-2032)
  2. 7.2 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026)
  4. 7.4 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021-2032)
  2. 8.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026)
  4. 8.4 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021-2032)
  2. 9.2 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021-2032)
  2. 10.2 South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026)
  4. 10.4 South America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021-2032)
  2. 11.2 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 NuChem Sciences Inc
  2. 12.1.1 NuChem Sciences Inc Company Information
  3. 12.1.2 NuChem Sciences Inc Business Overview
  4. 12.1.3 NuChem Sciences Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  5. 12.1.4 NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  6. 12.1.5 NuChem Sciences Inc Recent Developments
  7. 12.2 Sygnature Discovery
  8. 12.2.1 Sygnature Discovery Company Information
  9. 12.2.2 Sygnature Discovery Business Overview
  10. 12.2.3 Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  11. 12.2.4 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  12. 12.2.5 Sygnature Discovery Recent Developments
  13. 12.3 Paraza Pharma, Inc
  14. 12.3.1 Paraza Pharma, Inc Company Information
  15. 12.3.2 Paraza Pharma, Inc Business Overview
  16. 12.3.3 Paraza Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  17. 12.3.4 Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  18. 12.3.5 Paraza Pharma, Inc Recent Developments
  19. 12.4 Dalriada
  20. 12.4.1 Dalriada Company Information
  21. 12.4.2 Dalriada Business Overview
  22. 12.4.3 Dalriada Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  23. 12.4.4 Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  24. 12.4.5 Dalriada Recent Developments
  25. 12.5 Inotiv
  26. 12.5.1 Inotiv Company Information
  27. 12.5.2 Inotiv Business Overview
  28. 12.5.3 Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  29. 12.5.4 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  30. 12.5.5 Inotiv Recent Developments
  31. 12.6 Eurofins Discovery
  32. 12.6.1 Eurofins Discovery Company Information
  33. 12.6.2 Eurofins Discovery Business Overview
  34. 12.6.3 Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  35. 12.6.4 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  36. 12.6.5 Eurofins Discovery Recent Developments
  37. 12.7 RTI International
  38. 12.7.1 RTI International Company Information
  39. 12.7.2 RTI International Business Overview
  40. 12.7.3 RTI International Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  41. 12.7.4 RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  42. 12.7.5 RTI International Recent Developments
  43. 12.8 Frontage Labs
  44. 12.8.1 Frontage Labs Company Information
  45. 12.8.2 Frontage Labs Business Overview
  46. 12.8.3 Frontage Labs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  47. 12.8.4 Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  48. 12.8.5 Frontage Labs Recent Developments
  49. 12.9 Labcorp
  50. 12.9.1 Labcorp Company Information
  51. 12.9.2 Labcorp Business Overview
  52. 12.9.3 Labcorp Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  53. 12.9.4 Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  54. 12.9.5 Labcorp Recent Developments
  55. 12.10 Jubilant Biosys
  56. 12.10.1 Jubilant Biosys Company Information
  57. 12.10.2 Jubilant Biosys Business Overview
  58. 12.10.3 Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  59. 12.10.4 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  60. 12.10.5 Jubilant Biosys Recent Developments
  61. 12.11 Creative Biolabs
  62. 12.11.1 Creative Biolabs Company Information
  63. 12.11.2 Creative Biolabs Business Overview
  64. 12.11.3 Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  65. 12.11.4 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  66. 12.11.5 Creative Biolabs Recent Developments
  67. 12.12 Evotec
  68. 12.12.1 Evotec Company Information
  69. 12.12.2 Evotec Business Overview
  70. 12.12.3 Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  71. 12.12.4 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  72. 12.12.5 Evotec Recent Developments
  73. 12.13 Charles River
  74. 12.13.1 Charles River Company Information
  75. 12.13.2 Charles River Business Overview
  76. 12.13.3 Charles River Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  77. 12.13.4 Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  78. 12.13.5 Charles River Recent Developments
  79. 12.14 Anthem Bio Sciences
  80. 12.14.1 Anthem Bio Sciences Company Information
  81. 12.14.2 Anthem Bio Sciences Business Overview
  82. 12.14.3 Anthem Bio Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  83. 12.14.4 Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  84. 12.14.5 Anthem Bio Sciences Recent Developments
  85. 12.15 Molecular Diagnostic Services, Inc
  86. 12.15.1 Molecular Diagnostic Services, Inc Company Information
  87. 12.15.2 Molecular Diagnostic Services, Inc Business Overview
  88. 12.15.3 Molecular Diagnostic Services, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  89. 12.15.4 Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  90. 12.15.5 Molecular Diagnostic Services, Inc Recent Developments
  91. 12.16 Invitrocue
  92. 12.16.1 Invitrocue Company Information
  93. 12.16.2 Invitrocue Business Overview
  94. 12.16.3 Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  95. 12.16.4 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  96. 12.16.5 Invitrocue Recent Developments
  97. 12.17 TCG Lifesciences Private Limited
  98. 12.17.1 TCG Lifesciences Private Limited Company Information
  99. 12.17.2 TCG Lifesciences Private Limited Business Overview
  100. 12.17.3 TCG Lifesciences Private Limited Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  101. 12.17.4 TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  102. 12.17.5 TCG Lifesciences Private Limited Recent Developments
  103. 12.18 Q 2 Solutions
  104. 12.18.1 Q 2 Solutions Company Information
  105. 12.18.2 Q 2 Solutions Business Overview
  106. 12.18.3 Q 2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  107. 12.18.4 Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  108. 12.18.5 Q 2 Solutions Recent Developments
  109. 12.19 WuXi AppTec
  110. 12.19.1 WuXi AppTec Company Information
  111. 12.19.2 WuXi AppTec Business Overview
  112. 12.19.3 WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  113. 12.19.4 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  114. 12.19.5 WuXi AppTec Recent Developments
  115. 12.20 oncodesign service
  116. 12.20.1 oncodesign service Company Information
  117. 12.20.2 oncodesign service Business Overview
  118. 12.20.3 oncodesign service Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  119. 12.20.4 oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  120. 12.20.5 oncodesign service Recent Developments
  121. 12.21 Alliance Pharma, Inc
  122. 12.21.1 Alliance Pharma, Inc Company Information
  123. 12.21.2 Alliance Pharma, Inc Business Overview
  124. 12.21.3 Alliance Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  125. 12.21.4 Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  126. 12.21.5 Alliance Pharma, Inc Recent Developments
  127. 12.22 QPS Holdings
  128. 12.22.1 QPS Holdings Company Information
  129. 12.22.2 QPS Holdings Business Overview
  130. 12.22.3 QPS Holdings Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  131. 12.22.4 QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  132. 12.22.5 QPS Holdings Recent Developments
  133. 12.23 NUVISAN
  134. 12.23.1 NUVISAN Company Information
  135. 12.23.2 NUVISAN Business Overview
  136. 12.23.3 NUVISAN Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021-2026)
  137. 12.23.4 NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Product Portfolio
  138. 12.23.5 NUVISAN Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst